ASPIRA WOMEN'S HEALTH INC.

Analyst Reco. Aspira Women's Health Inc.

Equities

AWH

US04537Y2081

Delayed Nasdaq Other stock markets 15:37:13 02/05/2024 BST			5-day change	1st Jan Change
3.18 ^USD	-1.24%		-3.05%	-22.06%

02:00pm	Aspira Women's Health Inc. Enhances Its Commercial Offering with the Formal Launch of Longitudinal Monitoring Feature of Ovawatch	CI
04-26	Aspira Women's Health Inc. Announces Minh Merchant Resigns as General Counsel, Chief Compliance Officer, and Corporate Secretary, Effective May 6, 2024	CI

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Cantor Fitzgerald Trims Price Target on Aspira Women's Health to $3.30 From $4, Maintains Neutral Rating	04-01	MT
Alliance Global Starts Aspira Women's Health With Buy Rating, $5.60 Price Target	22/08/23	MT
Cantor Fitzgerald Increases Price Target on Aspira Women's Health to $4.50 From $2, Maintains Neutral Rating	17/05/23	MT
Cantor Fitzgerald Downgrades Aspira Women's Health to Neutral From Overweight, Adjusts Price Target to $2 From $3	20/01/23	MT
Wall Street Stabilizes Pre-Bell After Slump Fueled by Rate Hike Concerns	23/08/22	MT
ASPIRA WOMEN HEALTH : Truist Securities Starts Aspira Women's Health at Buy With $12 Price Target	29/03/21	MT
ASPIRA WOMEN HEALTH : Cantor Fitzgerald Starts Aspira Women's Health at Overweight With $10 Price Target	29/01/21	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Secure and Increase the Performance of your Investments with our Team of Experts at your Side

Securing my Investments

fermer